Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial
Lindemann, K., Kristensen, G., Mirza, M. R., Davies, L., Hilpert, F., Romero, I., Ayhan, A., Burges, A., Rubio, M. J., Raspagliesi, F., Huizing, M., Creemers, G.-J., Lykka, M., Lee, C. K., Gebski, V.,Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw238
Date:
August, 2016
File:
PDF, 182 KB
english, 2016